Hasil Pencarian - Ralf Linker

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Clinical trials in multiple sclerosis: potential future trial designs

    Clinical trials in multiple sclerosis: potential future trial designs oleh Navid Manouchehri, Yinan Zhang, Amber Salter, Rehana Z. Hussain, Hans-Peter Hartung, Bernhard Hemmer, Ralf Linker, Benjamin M. Segal, Gary Cutter, Olaf Stüve

    Diterbitkan 2019-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis.

    Temporal pattern of ICAM-I mediated regulatory T cell recruitment to sites of inflammation in adoptive transfer model of multiple sclerosis. oleh Sebastian Doerck, Kerstin Göbel, Gesa Weise, Tilman Schneider-Hohendorf, Michael Reinhardt, Peter Hauff, Nicholas Schwab, Ralf Linker, Mathias Mäurer, Sven G Meuth, Heinz Wiendl

    Diterbitkan 2010-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide

    Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide oleh Bart Van Wijmeersch, Bart Van Wijmeersch, Bart Van Wijmeersch, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Patrick Vermersch, Maura Pugliatti, Maura Pugliatti, Carlo Pozzilli, Nikolaos Grigoriadis, Mona Alkhawajah, Laura Airas, Ralf Linker, Celia Oreja-Guevara, Celia Oreja-Guevara

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in

    Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year in oleh Maura Pugliatti, Maura Pugliatti, Hans-Peter Hartung, Hans-Peter Hartung, Hans-Peter Hartung, Celia Oreja-Guevara, Celia Oreja-Guevara, Carlo Pozzilli, Laura Airas, Laura Airas, Mona Alkhawajah, Mona Alkhawajah, Nikolaos Grigoriadis, Melinda Magyari, Bart Van Wijmeersch, Bart Van Wijmeersch, Bart Van Wijmeersch, Magd Zakaria, Ralf Linker, Andrew Chan, Patrick Vermersch, Thomas Berger, Thomas Berger

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Ethanol consumption inhibits TFH cell responses and the development of autoimmune arthritis

    Ethanol consumption inhibits TFH cell responses and the development of autoimmune arthritis oleh Vugar Azizov, Katharina Dietel, Franziska Steffen, Kerstin Dürholz, Julia Meidenbauer, Sébastien Lucas, Michael Frech, Yasunori Omata, Narges Tajik, Lisa Knipfer, Anne Kolenbrander, Silvia Seubert, Dennis Lapuente, Maria V. Sokolova, Jörg Hofmann, Matthias Tenbusch, Andreas Ramming, Ulrike Steffen, Falk Nimmerjahn, Ralf Linker, Stefan Wirtz, Martin Herrmann, Vladimir Temchura, Kerstin Sarter, Georg Schett, Mario M. Zaiss

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study

    Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study oleh Stefan Bittner, Falk Steffen, Timo Uphaus, Muthuraman Muthuraman, Vinzenz Fleischer, Anke Salmen, Felix Luessi, Achim Berthele, Luisa Klotz, Sven G. Meuth, Antonios Bayas, Friedemann Paul, Hans-Peter Hartung, Ralf Linker, Christoph Heesen, Martin Stangel, Brigitte Wildemann, Florian Then Bergh, Björn Tackenberg, Tania Kuempfel, Frank Weber, Uwe K. Zettl, Ulf Ziemann, Hayrettin Tumani, Sergiu Groppa, Mark Mühlau, Carsten Lukas, Bernhard Hemmer, Heinz Wiendl, Ralf Gold, Frauke Zipp

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper)

    Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper) oleh Heinz Wiendl, Ralf Gold, Thomas Berger, Tobias Derfuss, Ralf Linker, Mathias Mäurer, Orhan Aktas, Karl Baum, Martin Berghoff, Stefan Bittner, Andrew Chan, Adam Czaplinski, Florian Deisenhammer, Franziska Di Pauli, Renaud Du Pasquier, Christian Enzinger, Elisabeth Fertl, Achim Gass, Klaus Gehring, Claudio Gobbi, Norbert Goebels, Michael Guger, Aiden Haghikia, Hans-Peter Hartung, Fedor Heidenreich, Olaf Hoffmann, Boris Kallmann, Christoph Kleinschnitz, Luisa Klotz, Verena I. Leussink, Fritz Leutmezer, Volker Limmroth, Jan D. Lünemann, Andreas Lutterotti, Sven G. Meuth, Uta Meyding-Lamadé, Michael Platten, Peter Rieckmann, Stephan Schmidt, Hayrettin Tumani, Frank Weber, Martin S. Weber, Uwe K. Zettl, Tjalf Ziemssen, Frauke Zipp

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: